Key concepts and limitations of statistical methods for evaluating biomarkers of kidney disease
Clicks: 288
ID: 271386
2014
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.6
/100
2 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Interest in developing and using novel markers of kidney injury is increasing. To maintain scientific rigour in these endeavors, a comprehensive understanding of statistical methodology is required to rigorously assess the incremental value of novel biomarkers in existing clinical risk prediction mo ā¦| Reference Key |
cr2014journalkey
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Parikh CR;Thiessen-Philbrook H;; |
| Journal | journal of the american society of nephrology : jasn |
| Year | 2014 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
reproducibility of results
research support
N.I.H.
Extramural
biomarkers*
risk
odds ratio
predictive value of tests
roc curve
area under curve
decision support techniques
kidney diseases / etiology
pmid:24790177
pmc4116071
doi:10.1681/asn.2013121300
chirag r parikh
heather thiessen-philbrook
kidney diseases / diagnosis*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.